| ACF | Aberrant crypt foci |
| cAMP | Cyclic adenosine monophosphate |
| AOM | Azoxymethane |
| CAFs | Cancer-associated fibroblasts |
| COX-2 | Cyclooxygenase-2 |
| CRC | Colorectal cancer |
| CRTC1 | Camp response element-binding protein-regulated transcription co-activator 1 |
| DSS | Dextran sulfate sodium |
| ERK | Extracellular signal-regulated kinase |
| GPCR | G protein-coupled receptor |
| IBD | Inflammatory bowel disease |
| IDO | Indoleamine 2,3-dioxygenase |
| MDSCs | Myeloid-derived suppressor cells |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK cells | Natural killer cells |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| PI3K | Phosphoinositide 3-kinase |
| PKA | Protein kinase A |
| RNI | Reactive nitrogen intermediates |
| ROS | Reactive oxygen species |
| TAFs | Tumor associated fibroblasts |
| TAM | Tumor-associated macrophages |
| TAN | Tumor associated neutrophils |
| TME | Tumor microenvironment |
| VEGF | Vascular endothelial growth factor |
| VEGFR | Vascular endothelial growth factor receptor |